Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; AlphaCore5, a patient warming system for prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for management of body temperature in neonates. Inspiration Healthcare Group plc was founded in 1998 and is headquartered in Crawley, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in United Kingdom. The company was established in the 2015. The company's ISIN is GB00BXDZL105.
TickerIHC
Long NameInspiration Healthcare Group PLC
Short NameInspiration Healthcare
SectorHealthcare
SubsectorMedical Devices
Subsector 2Health Care
CurrencyGBX
ISINGB00BXDZL105